AH Bio Fund IV, L.P.

BRVE

AH Bio Fund IV, L.P. serves as 10 percent owner at BRVE (BRVE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$19.80M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$19.80M

Companies Traded

BRVE

Active Period

Aug 2026

1 total trades

Most Recent

Buy BRVE

Aug 11, 2026 · $19.80M

AH Bio Fund IV, L.P.'s Insider Trading at BRVE (BRVE)

Buys

1 · $19.80M

Sells

0 · $0.00

Total Shares Bought

1,100,000

Total Shares Sold

BRVE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 11, 2026	Buy	1,100,000	$18.00	$19.80M	10,232,420

Related Insiders

Erez Chimovits

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

David Charles Lubner

director

BRVEBuy · Aug 7, 2026

David I Malek

director

BRVEBuy · Aug 7, 2026

Travis Murdoch

director, officer: CEO and President

BRVEBuy · Aug 7, 2026

James Paul Rickey

officer: Chief Financial Officer

BRVEBuy · Aug 7, 2026

Michele A. Anderson

officer: Chief Development Officer

BRVEBuy · Aug 7, 2026

Christopher Viehbacher

director

BRVEBuy · Aug 7, 2026

Explore More Insider Trading Data

BRVE Insider Trading Activity

View all insider trades at BRVE

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity